| answer text |
<p>NHS England held a three month consultation between July and October 2017 on draft
guidance for clinical commissioning groups’ (CCGs’) proposed restrictions on the routine
prescribing of 18 products, totalling £141 million in National Health Service primary
care spend. Final statutory guidance ‘Items which should not be routinely prescribed
in primary care: Guidance for CCGs’ was published on 30 November 2017.</p><p> </p><p>NHS
England is responsible for monitoring the effect of its new guidance relating to items
that should not routinely be prescribed in primary care. NHS England does not hold
information on how many CCG guidelines have been updated, or how much funding has
been saved since the guidance was published. The NHS Business Services Authority has
a dashboard which monitors, on a monthly basis, prescribing volume and costs of the
18 products identified in the CCG guidance. NHS England plans to utilise this dashboard
to monitor implementation and progress.</p>
|
 |
